로딩 중…
지수 로딩 중…
Theravance Biopharma, Inc.
TBPH· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
KY
KY$16.58-0.78%
2026-06-18
Price Chart
Theravance Biopharma, Inc.+56.12%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $855M |
| Revenue | $110M |
| Net Income | $115M |
| Total Assets | $472M |
| Net Assets | $291M |
| Value | |
| P/E | 7.46x |
| P/B | 2.94x |
| P/S | 7.79x |
| EV/EBITDA | 80.11x |
| FCF Yield | 31.44% |
| Profitability | |
| ROE | 39.42% |
| ROA | 24.25% |
| Op. Margin | 0.08% |
| Revenue Growth | 15.02% |
| Financial Health | |
| Debt Ratio | 62.53% |
| Total Debt | $73M |
| FCF | $269M |
| Cash | $288M |
| Current Ratio | 13.14x |
| Net Debt/EBITDA | -26.89x |
| Performance | |
| 1Y Return | 56.12% |
| 1M Return | 2.03% |
| From 52W High | -21.16% |
| 1Y MDD | -34.57% |
| Trading | |
| Volume | 792,334 shares |
| Trading Value | $13M |
| Per Share | |
| EPS | $2.08 |
| BPS | $9.55 |